bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Data from The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Authors: Manca Paolo , Corallo Salvatore , Busico Adele , Lonardi Sara , Corti Francesca , Antoniotti Carlotta , Procaccio Letizia , Clavarezza Matteo , Smiroldo Valeria , Tomasello Gianluca , Murialdo Roberto , Sartore-Bianchi Andrea , Racca Patrizia , Pagani Filippo , Randon Giovanni , Martinetti Antonia , Sottotetti Elisa , Palermo Federica , Perrone Federica , Tamborini Elena , Prisciandaro Michele , Raimondi Alessandra , Di Bartolomeo Maria , Morano Federica , Pietrantonio Filippo
Published: April 2023

Suppl Fig 4
Supplementary Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas
Authors: Wo Jennifer Y. , Clark Jeffrey W. , Eyler Christine E. , Mino-Kenudson Mari , Klempner Samuel J. , Allen Jill N. , Keane Florence K. , Parikh Aparna R. , Roeland Eric , Drapek Lorraine C. , Ryan David P. , Corcoran Ryan B. , Van Seventer Emily , Fetter Isobel J. , Shahzade Heather A. , Khandekar Melin J. , Lanuti Michael , Morse Christopher R. , Heist Rebecca S. , Ulysse Christine A. , Christopher Benjamin , Baglini Christian , Yeap Beow Y. , Mullen John T. , Hong Theodore S.
Published: April 2023

Supplemental Appendix 8: TCGA gastric tumor analysis
Supplementary Data from The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Authors: Manca Paolo , Corallo Salvatore , Busico Adele , Lonardi Sara , Corti Francesca , Antoniotti Carlotta , Procaccio Letizia , Clavarezza Matteo , Smiroldo Valeria , Tomasello Gianluca , Murialdo Roberto , Sartore-Bianchi Andrea , Racca Patrizia , Pagani Filippo , Randon Giovanni , Martinetti Antonia , Sottotetti Elisa , Palermo Federica , Perrone Federica , Tamborini Elena , Prisciandaro Michele , Raimondi Alessandra , Di Bartolomeo Maria , Morano Federica , Pietrantonio Filippo
Published: April 2023

Legends to supplementary figures
Supplementary Data from The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Authors: Manca Paolo , Corallo Salvatore , Busico Adele , Lonardi Sara , Corti Francesca , Antoniotti Carlotta , Procaccio Letizia , Clavarezza Matteo , Smiroldo Valeria , Tomasello Gianluca , Murialdo Roberto , Sartore-Bianchi Andrea , Racca Patrizia , Pagani Filippo , Randon Giovanni , Martinetti Antonia , Sottotetti Elisa , Palermo Federica , Perrone Federica , Tamborini Elena , Prisciandaro Michele , Raimondi Alessandra , Di Bartolomeo Maria , Morano Federica , Pietrantonio Filippo
Published: April 2023

Suppl Table 2
Supplementary Table 4 from Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Authors: Nguyen Cong Trung , Caruso Stefano , Maille Pascale , Beaufrère Aurélie , Augustin Jérémy , Favre Loetitia , Pujals Anaïs , Boulagnon-Rombi Camille , Rhaiem Rami , Amaddeo Giuliana , di Tommaso Luca , Luciani Alain , Regnault Hélène , Brustia Raffaele , Scatton Olivier , Charlotte Frédéric , Brochériou Isabelle , Sommacale Daniele , Soussan Patrick , Leroy Vincent , Laurent Alexis , Le Van Ky , Ta Van To , Trinh Hong Son , Tran Thi Lan , Gentien David , Rapinat Audrey , Nault Jean Charles , Allaire Manon , Mulé Sebastien , Zucman-Rossi Jessica , Pawlotsky Jean-Michel , Tournigand Christophe , Lafdil Fouad , Paradis Valérie , Calderaro Julien
Published: April 2023

Supplementary Table 4: Difference in gene expression between IL1 and IL2 subtypes IL: Immune - Low
Supplementary Figure 3 from PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases
Authors: Kim Guowei , Tan Hon Lyn , Sundar Raghav , Lieske Bettina , Chee Cheng Ean , Ho Jingshan , Shabbir Asim , Babak Maria V. , Ang Wee Han , Goh Boon Cher , Yong Wei Peng , Wang Lingzhi , So Jimmy B.Y.
Published: April 2023

The area under the curve(AUC) ratio (Ultrafiltrate(UF) vs Plasmatot) at different dose levels
Supplementary Table 3 from Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
Authors: Nguyen Cong Trung , Caruso Stefano , Maille Pascale , Beaufrère Aurélie , Augustin Jérémy , Favre Loetitia , Pujals Anaïs , Boulagnon-Rombi Camille , Rhaiem Rami , Amaddeo Giuliana , di Tommaso Luca , Luciani Alain , Regnault Hélène , Brustia Raffaele , Scatton Olivier , Charlotte Frédéric , Brochériou Isabelle , Sommacale Daniele , Soussan Patrick , Leroy Vincent , Laurent Alexis , Le Van Ky , Ta Van To , Trinh Hong Son , Tran Thi Lan , Gentien David , Rapinat Audrey , Nault Jean Charles , Allaire Manon , Mulé Sebastien , Zucman-Rossi Jessica , Pawlotsky Jean-Michel , Tournigand Christophe , Lafdil Fouad , Paradis Valérie , Calderaro Julien
Published: April 2023

Supplementary Table 3: Difference in gene expression between IH1 and IH2 subtypes IH: Immune - High
Supplementary Figure 2 from PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases
Authors: Kim Guowei , Tan Hon Lyn , Sundar Raghav , Lieske Bettina , Chee Cheng Ean , Ho Jingshan , Shabbir Asim , Babak Maria V. , Ang Wee Han , Goh Boon Cher , Yong Wei Peng , Wang Lingzhi , So Jimmy B.Y.
Published: April 2023

Mean concentration-time profiles of pressurized intraperitoneal aerosol chemotherapy (PIPAC) oxaliplatin (n = 14) in plasmatot (A) and ultrafiltrate (B)
Supplementary Figure S6 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
Authors: Zhang Pu , Brinton Lindsey T. , Williams Katie , Sher Steven , Orwick Shelley , Tzung-Huei Lai , Mims Alice S. , Coss Christopher C. , Kulp Samuel K. , Youssef Youssef , Chan Wing Keung , Mitchell Shaneice , Mustonen Allison , Cannon Matthew , Phillips Hannah , Lehman Amy M. , Kauffman Tierney , Beaver Larry , Canfield Daniel , Grieselhuber Nicole R. , Alinari Lapo , Sampath Deepa , Yan Pearlly , Byrd John C. , Blachly James S. , Lapalombella Rosa
Published: April 2023

AR-42 and KPT-9274 treatments induce DNA repair defects.
Supplementary Figure S1 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
Authors: Zhang Pu , Brinton Lindsey T. , Williams Katie , Sher Steven , Orwick Shelley , Tzung-Huei Lai , Mims Alice S. , Coss Christopher C. , Kulp Samuel K. , Youssef Youssef , Chan Wing Keung , Mitchell Shaneice , Mustonen Allison , Cannon Matthew , Phillips Hannah , Lehman Amy M. , Kauffman Tierney , Beaver Larry , Canfield Daniel , Grieselhuber Nicole R. , Alinari Lapo , Sampath Deepa , Yan Pearlly , Byrd John C. , Blachly James S. , Lapalombella Rosa
Published: April 2023

Knockdown of selected genes has modest effects on MOLM13 responses to KPT-9274 treatment.
Figure S4 from Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription
Authors: Pang John , Nguyen Nam , Luebeck Jens , Ball Laurel , Finegersh Andrey , Ren Shuling , Nakagawa Takuya , Flagg Mitchell , Sadat Sayed , Mischel Paul S. , Xu Guorong , Fisch Kathleen , Guo Theresa , Cahill Gabrielle , Panuganti Bharat , Bafna Vineet , Califano Joseph
Published: April 2023

Principal component analyses of utilization of canonical HPV splice sites in institutional and TCGA cohorts.
Supplementary Table from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer
Authors: Dylgjeri Emanuela , Kothari Vishal , Shafi Ayesha A. , Semenova Galina , Gallagher Peter T. , Guan Yi F. , Pang Angel , Goodwin Jonathan F. , Irani Swati , McCann Jennifer J. , Mandigo Amy C. , Chand Saswati , McNair Christopher M. , Vasilevskaya Irina , Schiewer Matthew J. , Lallas Costas D. , McCue Peter A. , Gomella Leonard G. , Seifert Erin L. , Carroll Jason S. , Butler Lisa M. , Holst Jeff , Kelly William K. , Knudsen Karen E.
Published: April 2023

Supplementary Table from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer
Supplementary Table S6 from Cell Type–specific Adaptive Signaling Responses to KRASG12C Inhibition
Authors: Solanki Hitendra S. , Welsh Eric A. , Fang Bin , Izumi Victoria , Darville Lancia , Stone Brandon , Franzese Ryan , Chavan Sandip , Kinose Fumi , Imbody Denis , Koomen John M. , Rix Uwe , Haura Eric B.
Published: April 2023

Supplementary Table S6. LC-MRM quantification of peptides representing CDH1 and CDH2 expression in H358, Calu1 and H1792 cells.
Supplementary Figures from Cell Type–specific Adaptive Signaling Responses to KRASG12C Inhibition
Authors: Solanki Hitendra S. , Welsh Eric A. , Fang Bin , Izumi Victoria , Darville Lancia , Stone Brandon , Franzese Ryan , Chavan Sandip , Kinose Fumi , Imbody Denis , Koomen John M. , Rix Uwe , Haura Eric B.
Published: April 2023

Supplementary Fig. S1. Differential response (2D and 3D culture) of KRASG12C specific covalent inhibitors (ARS-1620 and AMG510) in KRASG12C lung cancer cell lines and signaling rebound following KRASG12C inhibition. Supplementary Fig. S2. MetaCore literature network after ARS-1620 treatment in H358 cells. Supplementary Fig. S3. TMT design for expression and pY comparison in 8 KRASG12C lung cancer cell lines and two group comparison of phosphosites Supplementary Fig. S4. Analysis of CCLE data set for EMT markers and ERBB3 gene expression; and PCA representing 105 probeset TGFβ-EMT signatures (Gordian et al. 2019) translated into proteins expression to describe EMT activity in KRASG12C lung cancer cell lines. Supplementary Fig. S5. Impact of SHP2 inhibitors (SHP-099 and RMC-4550) on signaling in H358 cells and cell viability analysis following treatment with SHP2 inhibitors or in the combination with ARS-1620 in H358 and H1792 cells. Supplementary Fig. S6. Literature-based signaling network after KRASG12C inhibition in H1792 cells and cell viability analysis following treatment with ARS-1620 (1µM), AZD-4547 (1µM) and their combination in NSCLCG12C mutant cell lines. Supplementary Fig. S7. Effect of TGFβ stimulation on cell viability in response to KRASG12C inhibition and different combination strategies. Supplementary Fig. S8. Heatmap showing mean-centered log abundance expression values for indicated phosphosites/protein expression in KRASG12C mutant cell lines and E vs M 2-group comparison performed for FGFR1 gene expression in CCLE data set. Supplementary Fig. S9. Literature-based signaling network after KRASG12C inhibition in Calu1 cells and impact on signaling following treatment with ARS-1620 plus drugs known to target AXL Receptor.
Supplementary Figure from ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
Authors: Sharma Sai Kiran , Mack Kyeara N. , Piersigilli Alessandra , Pourat Jacob , Edwards Kimberly J. , Keinänen Outi , Jiao Maria S. , Zhao Huiyong , White Brandy , Brooks Cory L. , de Stanchina Elisa , Madiyalakan Madi R. , Hollingsworth Michael A. , Radhakrishnan Prakash , Lewis Jason S. , Zeglis Brian M.
Published: April 2023

Supplementary Figure from ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
Supplementary Tables from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Authors: Westin Shannon N. , Labrie Marilyne , Litton Jennifer K. , Blucher Aurora , Fang Yong , Vellano Christopher P. , Marszalek Joseph R. , Feng Ningping , Ma XiaoYan , Creason Allison , Fellman Bryan , Yuan Ying , Lee Sanghoon , Kim Tae-Beom , Liu Jinsong , Chelariu-Raicu Anca , Chen Tsun Hsuan , Kabil Nashwa , Soliman Pamela T. , Frumovitz Michael , Schmeler Katheleen M. , Jazaeri Amir , Lu Karen H. , Murthy Rashmi , Meyer Larissa A. , Sun Charlotte C. , Sood Anil K. , Coleman Robert L. , Mills Gordon B.
Published: April 2023

Supplementary Tables
Figure_S6 from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Authors: Westin Shannon N. , Labrie Marilyne , Litton Jennifer K. , Blucher Aurora , Fang Yong , Vellano Christopher P. , Marszalek Joseph R. , Feng Ningping , Ma XiaoYan , Creason Allison , Fellman Bryan , Yuan Ying , Lee Sanghoon , Kim Tae-Beom , Liu Jinsong , Chelariu-Raicu Anca , Chen Tsun Hsuan , Kabil Nashwa , Soliman Pamela T. , Frumovitz Michael , Schmeler Katheleen M. , Jazaeri Amir , Lu Karen H. , Murthy Rashmi , Meyer Larissa A. , Sun Charlotte C. , Sood Anil K. , Coleman Robert L. , Mills Gordon B.
Published: April 2023

Supplementary Figure S6
Figure_S5 from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Authors: Westin Shannon N. , Labrie Marilyne , Litton Jennifer K. , Blucher Aurora , Fang Yong , Vellano Christopher P. , Marszalek Joseph R. , Feng Ningping , Ma XiaoYan , Creason Allison , Fellman Bryan , Yuan Ying , Lee Sanghoon , Kim Tae-Beom , Liu Jinsong , Chelariu-Raicu Anca , Chen Tsun Hsuan , Kabil Nashwa , Soliman Pamela T. , Frumovitz Michael , Schmeler Katheleen M. , Jazaeri Amir , Lu Karen H. , Murthy Rashmi , Meyer Larissa A. , Sun Charlotte C. , Sood Anil K. , Coleman Robert L. , Mills Gordon B.
Published: April 2023

Supplementary Figure S5
Supplementary Data from Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study
Authors: Li Jian , Cai Shirong , Zhou Yongjian , Zhang Jun , Zhou Ye , Cao Hui , Wu Xin , Deng Yanhong , Huang Zhao , Dong Juan , Shen Lin
Published: April 2023

Supplementary Data from Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study
Supplementary Table from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
Authors: Schuler Martin , Zimmer Lisa , Kim Kevin B. , Sosman Jeffrey A. , Ascierto Paolo A. , Postow Michael A. , De Vos Filip Y.F.L. , van Herpen Carla M.L. , Carlino Matteo S. , Johnson Douglas B. , Berking Carola , Reddy Micaela B. , Harney Allison S. , Berlin Jordan D. , Amaria Rodabe N.
Published: April 2023

Supplementary Table from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
Supplementary Data from Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia
Authors: Konopleva Marina , Thirman Michael J. , Pratz Keith W. , Garcia Jacqueline S. , Recher Christian , Pullarkat Vinod , Kantarjian Hagop M. , DiNardo Courtney D. , Dail Monique , Duan Yinghui , Chyla Brenda , Potluri Jalaja , Miller Catherine L. , Wei Andrew H.
Published: April 2023

Supplementary Data from Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia
Supplementary Table from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Authors: Ramaswami Ramya , Polizzotto Mark N. , Lurain Kathryn , Wyvill Kathleen M. , Widell Anaida , George Jomy , Goncalves Priscila , Steinberg Seth M. , Whitby Denise , Uldrick Thomas S. , Yarchoan Robert
Published: April 2023

Supplementary Table from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Supplementary Figure from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Authors: Ramaswami Ramya , Polizzotto Mark N. , Lurain Kathryn , Wyvill Kathleen M. , Widell Anaida , George Jomy , Goncalves Priscila , Steinberg Seth M. , Whitby Denise , Uldrick Thomas S. , Yarchoan Robert
Published: April 2023

Supplementary Figure from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Supplementary Data from Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
Authors: Zhang Zhanjie , Wu Bian , Peng Gang , Xiao Guixiang , Huang Jing , Ding Qian , Yang Chengzhang , Xiong Xingao , Ma Hui , Shi Liangliang , Yang Jinsong , Hong Xiaohua , Wei Jielin , Qin You , Wan Chao , Zhong Yi , Zhou Yan , Zhao Xueyan , Leng Yangming , Zhang Tao , Wu Gang , Yao Min , Zhang Xiaomeng , Yang Kunyu
Published: April 2023

Supplementary Data from Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
Supplementary Data from Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
Authors: Le Xiuning , Gleber-Netto Frederico O. , Rubin M. Laura , Qing Yun , Du Robyn , Kies Merrill , Blumenschein George , Lu Charles , Johnson Faye M. , Bell Diana , Lewis Jeff , Zhang Jiexin , Feng Lei , Wilson Kaye , Marcelo-Lewis Kathrina , Wang Jing , Ginsberg Lawrence , Gillison Maura , Lee J. Jack , Meric-Berstam Funda , Mills Gordon B. , Myers Jeffrey N. , Pickering Curtis R.
Published: April 2023

Supplementary Data from Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
Authors: Yang Qing , Hu Jiemiao , Jia Zhiliang , Wang Qi , Wang Jing , Dao Long Hoang , Zhang Wendong , Zhang Sheng , Xia Xueqing , Gorlick Richard , Li Shulin
Published: April 2023

Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Authors: Girardi Daniel M. , Niglio Scot A. , Mortazavi Amir , Nadal Rosa , Lara Primo , Pal Sumanta K. , Saraiya Biren , Cordes Lisa , Ley Lisa , Ortiz Olena Sierra , Cadena Jacqueline , Diaz Carlos , Bagheri Hadi , Redd Bernadette , Steinberg Seth M. , Costello Rene , Chan Keith S. , Lee Min-Jung , Lee Sunmin , Yu Yunkai , Gurram Sandeep , Chalfin Heather J. , Valera Vladimir , Figg William D. , Merino Maria , Toubaji Antoun , Streicher Howard , Wright John J. , Sharon Elad , Parnes Howard L. , Ning Yang-Min , Bottaro Donald P. , Cao Liang , Trepel Jane B. , Apolo Andrea B.
Published: April 2023

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Supplementary Data from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Authors: Vesely Clare , Wong Yien Ning Sophia , Childs Alexa , Akarca Ayse U. , Dhami Pawan , Vaikkinen Heli , Conde Lucia , Herrero Javier , Ogunbiyi Olagunju , Gander Amir , Luong Tu Vinh , Thirlwell Chrissie , Caplin Martyn , Toumpanakis Christos , Peggs Karl , Quezada Sergio A. , Marafioti Teresa , Meyer Tim
Published: April 2023

Supplementary Data from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Supplementary Data from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Authors: Hollis Robert L. , Meynert Alison M. , Michie Caroline O. , Rye Tzyvia , Churchman Michael , Hallas-Potts Amelia , Croy Ian , McCluggage W. Glenn , Williams Alistair R.W. , Bartos Clare , Iida Yasushi , Okamoto Aikou , Dougherty Brian , Barrett J. Carl , March Ruth , Matakidou Athena , Roxburgh Patricia , Semple Colin A. , Harkin D. Paul , Kennedy Richard , Herrington C. Simon , Gourley Charlie
Published: April 2023

Supplementary Data from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Supplementary Table from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
Authors: Hubbard Joleen M. , Tőke Enikő R. , Moretto Roberto , Graham Rondell P. , Youssoufian Hagop , Lőrincz Orsolya , Molnár Levente , Csiszovszki Zsolt , Mitchell Jessica L. , Wessling Jaclynn , Tóth József , Cremolini Chiara
Published: April 2023

Supplementary Table from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
Supplementary Figure from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
Authors: Hubbard Joleen M. , Tőke Enikő R. , Moretto Roberto , Graham Rondell P. , Youssoufian Hagop , Lőrincz Orsolya , Molnár Levente , Csiszovszki Zsolt , Mitchell Jessica L. , Wessling Jaclynn , Tóth József , Cremolini Chiara
Published: April 2023

Supplementary Figure from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
Supplementary Table from Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
Authors: Rohrer Bley Carla , Wolf Friederike , Gonçalves Jorge Patrik , Grilj Veljko , Petridis Ioannis , Petit Benoit , Böhlen Till T. , Moeckli Raphael , Limoli Charles , Bourhis Jean , Meier Valeria , Vozenin Marie-Catherine
Published: April 2023

Supplementary Table from Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
Supplementary Figure from Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
Authors: Rohrer Bley Carla , Wolf Friederike , Gonçalves Jorge Patrik , Grilj Veljko , Petridis Ioannis , Petit Benoit , Böhlen Till T. , Moeckli Raphael , Limoli Charles , Bourhis Jean , Meier Valeria , Vozenin Marie-Catherine
Published: April 2023

Supplementary Figure from Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
Supplementary Table from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Authors: Shah Manish A. , Shitara Kohei , Lordick Florian , Bang Yung-Jue , Tebbutt Niall C. , Metges Jean-Phillippe , Muro Kei , Lee Keun-Wook , Shen Lin , Tjulandin Sergei , Hays John L. , Starling Naureen , Xu Rui-Hua , Sturtz Keren , Fontaine Marilyn , Oh Cindy , Brooks Emily M. , Xu Bo , Li Wei , Li Chiang J. , Borodyansky Laura , Van Cutsem Eric
Published: April 2023

Supplementary Table from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Supplementary Data from Praluzatamab Ravtansine, a CD166-Targeting Antibody–Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Authors: Boni Valentina , Fidler Mary J. , Arkenau Hendrik-Tobias , Spira Alexander , Meric-Bernstam Funda , Uboha Nataliya , Sanborn Rachel E. , Sweis Randy F. , LoRusso Patricia , Nagasaka Misako , Garcia-Corbacho Javier , Jalal Shadia , Harding James J. , Kim Stella K. , Miedema Iris H.C. , Vugts Danielle J. , Huisman Marc C. , Zwezerijnen Gerben J.C. , van Dongen Guus A.M.S. , Menke van der Houven van Oordt C. Willemien , Wang Song , Dang Tam , Zein Ivan A. , Vasiljeva Olga , Lyman Susan K. , Paton Virginia , Hannah Alison , Liu Joyce F.
Published: April 2023

Supplementary Data from Praluzatamab Ravtansine, a CD166-Targeting Antibody–Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Supplementary Figure from Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
Authors: Fischer Catherine G. , Pallavajjala Aparna , Jiang LiQun , Anagnostou Valsamo , Tao Jessica , Adams Emily , Eshleman James R. , Gocke Christopher D. , Lin Ming-Tseh , Platz Elizabeth A. , Xian Rena R.
Published: April 2023

Supplementary Figure from Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
Supplementary Figure from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Authors: Shah Manish A. , Shitara Kohei , Lordick Florian , Bang Yung-Jue , Tebbutt Niall C. , Metges Jean-Phillippe , Muro Kei , Lee Keun-Wook , Shen Lin , Tjulandin Sergei , Hays John L. , Starling Naureen , Xu Rui-Hua , Sturtz Keren , Fontaine Marilyn , Oh Cindy , Brooks Emily M. , Xu Bo , Li Wei , Li Chiang J. , Borodyansky Laura , Van Cutsem Eric
Published: April 2023

Supplementary Figure from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Supplementary Figure from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Authors: Meric-Bernstam Funda , Tannir Nizar M. , Iliopoulos Othon , Lee Richard J. , Telli Melinda L. , Fan Alice C. , DeMichele Angela , Haas Naomi B. , Patel Manish R. , Harding James J. , Voss Martin H. , Owonikoko Taofeek K. , Carthon Bradley , Srinivasan Ramaprasad , Bendell Johanna C. , Jenkins Yonchu , Whiting Sam H. , Orford Keith , Bennett Mark K. , Bauer Todd M.
Published: April 2023

Supplementary Figure from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Authors: Meric-Bernstam Funda , Tannir Nizar M. , Iliopoulos Othon , Lee Richard J. , Telli Melinda L. , Fan Alice C. , DeMichele Angela , Haas Naomi B. , Patel Manish R. , Harding James J. , Voss Martin H. , Owonikoko Taofeek K. , Carthon Bradley , Srinivasan Ramaprasad , Bendell Johanna C. , Jenkins Yonchu , Whiting Sam H. , Orford Keith , Bennett Mark K. , Bauer Todd M.
Published: April 2023

Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Supplementary Data from Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma
Authors: Monfrini Chiara , Stella Federico , Aragona Vanessa , Magni Martina , Ljevar Silva , Vella Cristina , Fardella Eugenio , Chiappella Annalisa , Nanetti Francesca , Pennisi Martina , Dodero Anna , Guidetti Anna , Corradini Paolo , Carniti Cristiana
Published: April 2023

Supplementary Data from Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma
Supplementary Table from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Authors: Kim Tae Won , Burris Howard A. , de Miguel Luken Maria J. , Pishvaian Michael J. , Bang Yung-Jue , Gordon Michael , Awada Ahmad , Camidge D. Ross , Hodi F. Stephen , McArthur Grant A. , Miller Wilson H. , Cervantes Andres , Chow Laura Q. , Lesokhin Alexander M. , Rutten Annemie , Sznol Mario , Rishipathak Deepali , Chen Shang-Chiung , Stefanich Eric , Pourmohamad Tony , Anderson Maria , Kim Jeong , Huseni Mahrukh , Rhee Ina , Siu Lillian L.
Published: April 2023

Supplementary Table from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Supplementary Table from Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Authors: Siravegna Giulia , O'Boyle Connor J. , Varmeh Shohreh , Queenan Natalia , Michel Alexa , Stein Jarrod , Thierauf Julia , Sadow Peter M. , Faquin William C. , Perry Simon K. , Bard Adam Z. , Wang Wei , Deschler Daniel G. , Emerick Kevin S. , Varvares Mark A. , Park Jong C. , Clark John R. , Chan Annie W. , Andreu Arasa Vanessa Carlota , Sakai Osamu , Lennerz Jochen , Corcoran Ryan B. , Wirth Lori J. , Lin Derrick T. , Iafrate A. John , Richmon Jeremy D. , Faden Daniel L.
Published: April 2023

Supplementary Table from Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Supplementary Figure from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Authors: Kim Tae Won , Burris Howard A. , de Miguel Luken Maria J. , Pishvaian Michael J. , Bang Yung-Jue , Gordon Michael , Awada Ahmad , Camidge D. Ross , Hodi F. Stephen , McArthur Grant A. , Miller Wilson H. , Cervantes Andres , Chow Laura Q. , Lesokhin Alexander M. , Rutten Annemie , Sznol Mario , Rishipathak Deepali , Chen Shang-Chiung , Stefanich Eric , Pourmohamad Tony , Anderson Maria , Kim Jeong , Huseni Mahrukh , Rhee Ina , Siu Lillian L.
Published: April 2023

Supplementary Figure from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Authors: Li Jiannong , Smalley Inna , Chen Zhihua , Wu Jheng-Yu , Phadke Manali S. , Teer Jamie K. , Nguyen Thanh , Karreth Florian A. , Koomen John M. , Sarnaik Amod A. , Zager Jonathan S. , Khushalani Nikhil I. , Tarhini Ahmad A. , Sondak Vernon K. , Rodriguez Paulo C. , Messina Jane L. , Chen Y. Ann , Smalley Keiran S.M.
Published: April 2023

Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Supplementary Figure from Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
Authors: Llovet Josep M. , Singal Amit G. , Villanueva Augusto , Finn Richard S. , Kudo Masatoshi , Galle Peter R. , Ikeda Masafumi , Callies Sophie , McGrath Louise M. , Wang Chunxiao , Abada Paolo , Widau Ryan C. , Gonzalez-Gugel Elena , Zhu Andrew X.
Published: April 2023

Supplementary Figure from Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
Supplementary Data from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Authors: Li Jiannong , Smalley Inna , Chen Zhihua , Wu Jheng-Yu , Phadke Manali S. , Teer Jamie K. , Nguyen Thanh , Karreth Florian A. , Koomen John M. , Sarnaik Amod A. , Zager Jonathan S. , Khushalani Nikhil I. , Tarhini Ahmad A. , Sondak Vernon K. , Rodriguez Paulo C. , Messina Jane L. , Chen Y. Ann , Smalley Keiran S.M.
Published: April 2023

Supplementary Data from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Supplementary Table from A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Authors: Xu Yujin , Dong Baiqiang , Zhu Weiguo , Li Jiancheng , Huang Rong , Sun Zongwen , Yang Xinmei , Liu Liping , He Han , Liao Zhongxing , Guan Ni , Kong Yue , Wang Wanwei , Chen Jianxiang , He Huijuan , Qiu Guoqin , Zeng Ming , Pu Juan , Hu Wangyuan , Bao Yong , Liu Zhigang , Ma Jun , Jiang Hao , Du Xianghui , Hu Jin , Zhuang Tingting , Cai Jing , Huang Jin , Tao Hua , Liu Yuan , Liang Xiaodong , Zhou Juying , Tao Guangzhou , Zheng Xiao , Chen Ming
Published: April 2023

Supplementary Table from A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Supplementary Figure from A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Authors: Xu Yujin , Dong Baiqiang , Zhu Weiguo , Li Jiancheng , Huang Rong , Sun Zongwen , Yang Xinmei , Liu Liping , He Han , Liao Zhongxing , Guan Ni , Kong Yue , Wang Wanwei , Chen Jianxiang , He Huijuan , Qiu Guoqin , Zeng Ming , Pu Juan , Hu Wangyuan , Bao Yong , Liu Zhigang , Ma Jun , Jiang Hao , Du Xianghui , Hu Jin , Zhuang Tingting , Cai Jing , Huang Jin , Tao Hua , Liu Yuan , Liang Xiaodong , Zhou Juying , Tao Guangzhou , Zheng Xiao , Chen Ming
Published: April 2023

Supplementary Figure from A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Supplementary Data from A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Authors: Xu Yujin , Dong Baiqiang , Zhu Weiguo , Li Jiancheng , Huang Rong , Sun Zongwen , Yang Xinmei , Liu Liping , He Han , Liao Zhongxing , Guan Ni , Kong Yue , Wang Wanwei , Chen Jianxiang , He Huijuan , Qiu Guoqin , Zeng Ming , Pu Juan , Hu Wangyuan , Bao Yong , Liu Zhigang , Ma Jun , Jiang Hao , Du Xianghui , Hu Jin , Zhuang Tingting , Cai Jing , Huang Jin , Tao Hua , Liu Yuan , Liang Xiaodong , Zhou Juying , Tao Guangzhou , Zheng Xiao , Chen Ming
Published: April 2023

Supplementary Data from A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Supplementary Figure from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Authors: Liu Jiayong , Gao Tian , Tan Zhichao , Li Shu , Xu Jie , Bai Chujie , Xue Ruifeng , Xie Lu , Zhang Lu , Fan Zhengfu , Guo Wei
Published: April 2023

Supplementary Figure from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Supplementary Table from Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
Authors: Ton Thanh G.N. , Pal Navdeep , Trinh Huong , Mahrus Sami , Bretscher Michael T. , Machado Robson J.M. , Sadetsky Natalia , Chaudhary Nayan , Lu Michael W. , Riely Gregory J.
Published: April 2023

Supplementary Table from Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
Supplementary Table from ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study
Authors: Johnson Melissa , Dudek Arkadiusz Z. , Sukari Ammar , Call Justin , Kunk Paul R. , Lewis Karl , Gainor Justin F. , Sarantopoulos John , Lee Patrice , Golden Adele , Harney Allison , Rothenberg S. Michael , Zhang Yuanyuan , Goldman Jonathan W.
Published: April 2023

Supplementary Table from ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study
Supplementary Figure from Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
Authors: Ton Thanh G.N. , Pal Navdeep , Trinh Huong , Mahrus Sami , Bretscher Michael T. , Machado Robson J.M. , Sadetsky Natalia , Chaudhary Nayan , Lu Michael W. , Riely Gregory J.
Published: April 2023

Supplementary Figure from Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
Supplementary Table from Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Authors: Fendler Wolfgang P. , Pabst Kim M. , Kessler Lukas , Fragoso Costa Pedro , Ferdinandus Justin , Weber Manuel , Lippert Maria , Lueckerath Katharina , Umutlu Lale , Kostbade Karina , Mavroeidi Ilektra A. , Schuler Martin , Ahrens Marit , Rischpler Christoph , Bauer Sebastian , Herrmann Ken , Siveke Jens T. , Hamacher Rainer
Published: April 2023

Supplementary Table from Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Supplementary figures from Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial
Authors: Song Zhengbo , Lv Dongqing , Chen Shi-Qing , Huang Jianjin , Li Yuping , Ying Shenpeng , Wu Xiaoyu , Hua Feng , Wang Wenxian , Xu Chunwei , Bei Ting , Gao Chan , Sun Zhijian , Zhang Yiping , Lu Shun
Published: April 2023

Supplementary figures
Supplementary Figure from FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Authors: Kim Nina , Norsworthy Kelly J. , Subramaniam Sriram , Chen Haiyan , Manning Michael L. , Kitabi Eliford , Earp Justin , Ehrlich Lori A. , Okusanya Olanrewaju O. , Vallejo Jonathon , Gehrke Brenda J. , de Claro R. Angelo , Pazdur Richard
Published: April 2023

Supplementary Figure from FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Supplementary Data from Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
Authors: Lodrini Marco , Graef Josefine , Thole-Kliesch Theresa M. , Astrahantseff Kathy , Sprüssel Annika , Grimaldi Maddalena , Peitz Constantin , Linke Rasmus B. , Hollander Jan F. , Lankes Erwin , Künkele Annette , Oevermann Lena , Schwabe Georg , Fuchs Jörg , Szymansky Annabell , Schulte Johannes H. , Hundsdörfer Patrick , Eckert Cornelia , Amthauer Holger , Eggert Angelika , Deubzer Hedwig E.
Published: April 2023

Supplementary Data from Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Authors: Nathenson Michael J. , Hu Junxiao , Ratan Ravin , Somaiah Neeta , Hsu Robert , DeMaria Peter J. , Catoe Heath W. , Pang Angela , Subhawong Ty K. , Amini Behrang , Sweet Kevin , Feister Katharina , Malik Karan , Jagannathan Jyothi , Braschi-Amirfarzan Marta , Sheren Jamie , Caldas Yupanqui , Moreno Tellez Cristiam , Rosenberg Andrew E. , Lazar Alexander J. , Maki Robert G. , Benedetto Pasquale , Cohen Jonathan , Trent Jonathan C. , Ravi Vinod , Patel Shreyaskumar , Wilky Breelyn A.
Published: April 2023

Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Supplementary Figure from Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy
Authors: Chida Keigo , Kawazoe Akihito , Suzuki Toshihiro , Kawazu Masahito , Ueno Toshihide , Takenouchi Kazumasa , Nakamura Yoshiaki , Kuboki Yasutoshi , Kotani Daisuke , Kojima Takashi , Bando Hideaki , Mishima Saori , Kuwata Takeshi , Sakamoto Naoya , Watanabe Jun , Mano Hiroyuki , Ikeda Masafumi , Shitara Kohei , Endo Itaru , Nakatsura Tetsuya , Yoshino Takayuki
Published: April 2023

Supplementary Figure from Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy
Supplementary Table from Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI–Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Authors: Mack Philip C. , Miao Jieling , Redman Mary W. , Moon James , Goldberg Sarah B. , Herbst Roy S. , Melnick Mary Ann , Walther Zenta , Hirsch Fred R. , Politi Katerina , Kelly Karen , Gandara David R.
Published: April 2023

Supplementary Table from Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI–Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Authors: Sihag Smita , Nussenzweig Samuel C. , Walch Henry S. , Hsu Meier , Tan Kay See , De La Torre Sergio , Janjigian Yelena Y. , Maron Steven B. , Ku Geoffrey Y. , Tang Laura H. , Shah Pari M. , Wu Abraham , Jones David R. , Solit David B. , Schultz Nikolaus , Ganesh Karuna , Berger Michael F. , Molena Daniela
Published: April 2023

Supplementary Figure from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Supplementary Data from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors
Authors: Goldman Jonathan W. , Piha-Paul Sarina A. , Curti Brendan , Pedersen Katrina S. , Bauer Todd M. , Groenland Stefanie L. , Carvajal Richard D. , Chhaya Vaishali , Kirby Gray , McGlinchey Kelly , Hammond Scott A. , Streicher Katie , Townsley Danielle M. , Chae Young Kwang , Voortman Jens , Marabelle Aurelien , Powderly John
Published: April 2023

Supplementary Data from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors
Supplementary Data from Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial
Authors: Lynggaard Charlotte Duch , Grønhøj Christian , Jensen Siri B. , Christensen Robin , Specht Lena , Andersen Elo , Andersen Tobias T. , Ciochon Urszula M. , Rathje Gulla S. , Hansen Adam E. , Stampe Helene , Fischer-Nielsen Anne , von Buchwald Christian
Published: April 2023

Supplementary Data from Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial
Supplementary Data from Targeting Podoplanin for the Treatment of Osteosarcoma
Authors: Takemoto Ai , Takagi Satoshi , Ukaji Takao , Gyobu Nobuhiko , Kakino Mamoru , Takami Miho , Kobayashi Asami , Lebel Marie , Kawaguchi Tokuichi , Sugawara Minoru , Tsuji-Takayama Kazue , Ichihara Kenji , Funauchi Yuki , Ae Keisuke , Matsumoto Seiichi , Sugiura Yoshiya , Takeuchi Kengo , Noda Tetsuo , Katayama Ryohei , Fujita Naoya
Published: April 2023

Supplementary Data from Targeting Podoplanin for the Treatment of Osteosarcoma
Supplementary Data from Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Authors: Bellmunt Joaquim , de Wit Ronald , Fradet Yves , Climent Miguel A. , Petrylak Daniel P. , Lee Jae-Lyun , Fong Lawrence , Necchi Andrea , Sternberg Cora N. , O'Donnell Peter H. , Powles Thomas , Plimack Elizabeth R. , Bajorin Dean F. , Balar Arjun V. , Castellano Daniel , Choueiri Toni K. , Culine Stephane , Gerritsen Winald , Gurney Howard , Quinn David I. , Vuky Jacqueline , Vogelzang Nicholas J. , Cristescu Razvan , Lunceford Jared , Saadatpour Assieh , Loboda Andrey , Ma Junshui , Rajasagi Mohini , Godwin James Luke , Homet Moreno Blanca , Grivas Petros
Published: April 2023

Supplementary Data from Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Supplementary Table from Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
Authors: Sheehan Beshara , Neeb Antje , Buroni Lorenzo , Paschalis Alec , Riisnaes Ruth , Gurel Bora , Gil Veronica , Miranda Susana , Crespo Mateus , Guo Christina , Jiménez Vacas Juan , Figueiredo Ines , Ferreira Ana , Welti Jon , Yuan Wei , Carreira Suzanne , Sharp Adam , de Bono Johann
Published: April 2023

Supplementary Table from Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
Supplementary Table from Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Authors: Lu Yen-Shen , Im Seock-Ah , Colleoni Marco , Franke Fabio , Bardia Aditya , Cardoso Fatima , Harbeck Nadia , Hurvitz Sara , Chow Louis , Sohn Joohyuk , Lee Keun Seok , Campos-Gomez Saul , Villanueva Vazquez Rafael , Jung Kyung Hae , Babu K. Govind , Wheatley-Price Paul , De Laurentiis Michelino , Im Young-Hyuck , Kuemmel Sherko , El-Saghir Nagi , O'Regan Ruth , Gasch Claudia , Solovieff Nadia , Wang Craig , Wang Yongyu , Chakravartty Arunava , Ji Yan , Tripathy Debu
Published: April 2023

Supplementary Table from Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Supplementary Figure from Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Authors: Lu Yen-Shen , Im Seock-Ah , Colleoni Marco , Franke Fabio , Bardia Aditya , Cardoso Fatima , Harbeck Nadia , Hurvitz Sara , Chow Louis , Sohn Joohyuk , Lee Keun Seok , Campos-Gomez Saul , Villanueva Vazquez Rafael , Jung Kyung Hae , Babu K. Govind , Wheatley-Price Paul , De Laurentiis Michelino , Im Young-Hyuck , Kuemmel Sherko , El-Saghir Nagi , O'Regan Ruth , Gasch Claudia , Solovieff Nadia , Wang Craig , Wang Yongyu , Chakravartty Arunava , Ji Yan , Tripathy Debu
Published: April 2023

Supplementary Figure from Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Supplementary Figure from Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
Authors: Sheehan Beshara , Neeb Antje , Buroni Lorenzo , Paschalis Alec , Riisnaes Ruth , Gurel Bora , Gil Veronica , Miranda Susana , Crespo Mateus , Guo Christina , Jiménez Vacas Juan , Figueiredo Ines , Ferreira Ana , Welti Jon , Yuan Wei , Carreira Suzanne , Sharp Adam , de Bono Johann
Published: April 2023

Supplementary Figure from Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
Supplementary Data from Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study
Authors: Nowakowski Grzegorz S. , Yoon Dok Hyun , Peters Anthea , Mondello Patrizia , Joffe Erel , Fleury Isabelle , Greil Richard , Ku Matthew , Marks Reinhard , Kim Kibum , Zinzani Pier Luigi , Trotman Judith , Huang Dan , Waltl Eva E. , Winderlich Mark , Kurukulasuriya Nuwan C. , Ambarkhane Sumeet , Hess Georg , Salles Gilles
Published: April 2023

Supplementary Data from Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study